Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1520 participants
OBSERVATIONAL
2008-10-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient's Quality of Life Assessment 5 to 10 Years After Hospitalization in Intensive Care Unit for a Severe Bacterial Infection
NCT04005560
Research Project on the Risk of Discomfort, Pain, Alteration of Skin Condition in Bedpan Use by Patients and Caregivers
NCT06332495
2-year Mortality After COVID-19 in Nursing Home Residents
NCT06468761
Preventability of Infections in Residents of French Nursing Homes
NCT01069497
Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France
NCT04420286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Preliminary data showed that care satisfaction, usual indicator of quality of care, was associated with quality of life away from the hospital, especially in the field of orthopedics (prosthetic surgery). Satisfaction is an indicator currently collected in routine periodic surveys in all establishments. This project will test the hypothesis of the prognostic role of this satisfaction after a medical or a surgical treatment in people hospitalized for chronic disease.
Objective: The objective of this research is to investigate the prognostic value of satisfaction with care on the quality of life of patients with chronic disease hospital, at 6 months and 1 year of discharge.
Patients and methods: A multicenter cohort of 1520 patients hospitalized in medical and surgical units for chronic disease (in the field of cardiovascular, musculoskeletal, nephrology, urology, digestive, pulmonary or endocrine). Patients will respond to PJHQ satisfaction questionnaire at the waning of their hospital stay. The quality of life (SF-36) will be measured at 6 months and 1 year after hospitalization.
The socio-demographic characteristics, diagnosis, anxiety state (HAD), optimistic / pessimistic personality (LOT-R), comorbidities (Charlson and Functional comorbidity index), major health events (rehospitalization, death ) and the characteristics of the stays and care structure (cluster services) who welcomed them will be saved.
The number of subjects required was calculated based on a cluster sampling (13 poles or services between institutions) to highlight with a power of 80% a difference of 5 points of quality of life among the satisfied and less satisfied subjects.
Statistical analysis will study the relationship of satisfaction scores with QoL dimensions at 6 months and 1 year, in hierarchical regression multilevel models adjusted for confounding variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients hospitalized for treatment of chronic disease, defined as a disease lasting for more than 6 months, and confirmed by a validation committee
* Hospitalization motivation is:
* A care of an acute episode of a chronic disease
* A car of a worsening of chronic disease
* A new therapeutic of a chronic disease
Exclusion Criteria
* Patients with more than 5 hospitalizations during the previous 5 years (more than 1 per year)
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GUILLEMIN Francis, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francis GUILLEMIN, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHRU NANCY
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Satisqol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.